Supplementing the diet with a lysophospholipid form of eicosapentaenoic acid (EPA) (LPC-EPA) may increase EPA levels in the brain, opening up possibilities to tackle disorders such as depression.
Innovus Pharma, a San Diego-based marketer of dietary supplements and OTC products, has in recent weeks secured $3 million in additional funding, purchased an online sales platform as well as announced a pilot trial on a muscle health supplement.
Chinese/American company Lyxia has debuted as a new player in the algae omega-3s space with a highly refined EPA ingredient from a photosynthetic strain.
The European Medicines Agency (EMA) has said omega-3 fatty acid medicines are not effective in preventing further heart and blood vessels problems after heart attack – meaning medicines containing DHA and EPA for this purpose will no longer be authorised...
How can you create excitement in a mature and established category like omega-3? We chat with Andrew Aussie, COO of Coromega, who brought in marketing expertise from across categories to help an omega-3 brand evolve into a healthy fats brand.
Assessment of nutritional status and solutions to micronutrient deficiencies must be in sync if maternal and infant health is to improve, says Peter van Dael, DSM's Senior VP of Nutrition Science and Advocacy.
The importance of adequate nutrition and targeted supplementation for war fighters is a rapidly evolving field, according to an expert who has counseled sailors on the subject.
Despite the equivocal reports in the mainstream media of the recently released omega-3s trials, the huge statistical power of the studies means the promising secondary endpoints can be trusted, experts say.
Dietary supplements have held out the promise of greater health. Has the category delivered on that promise? Are people healthier now than they were decades ago?
Krill-derived omega-3 fatty acids appear to reduce fasting levels of blood glucose, a Rimfrost-funded study finds, as researchers point to its supplementation as an effective approach in reducing cardiovascular disease (CVD) risk.
